Recordati Industria Chimica e Farmaceutica
A global pharmaceutical group that researches, develops, and markets medicines.
REC | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0003828271 (+4 more)
- LEI:
- 815600FBF92FD3531704
- Country:
- Italy
- Address:
- VIA MATTEO CIVITALI, 1, 20148 MILANO
- Website:
- https://recordati.com/it/
- Sector:
- Manufacturing
Description
Recordati Industria Chimica e Farmaceutica is a global pharmaceutical group engaged in the research, development, manufacturing, and commercialization of medicines and pharmaceutical chemicals. The company's operations are structured across three main areas: specialty and primary care, rare diseases, and consumer healthcare. It provides a range of prescription and self-medication treatments for both common and rare conditions, with a core therapeutic focus that includes cardiovascular diseases. The group develops and markets treatment options for a wide spectrum of health needs, serving patients in approximately 150 countries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-03 20:09 |
RECORDATI: UPDATE ON THE EXECUTION OF THE SHARE BUY-BACK PROGRAM
|
English | 3.7 MB | ||
| 2021-03-03 19:58 |
RECORDATI: AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO DI AZIONI PR…
|
Italian | 3.7 MB | ||
| 2021-02-22 18:25 |
RECORDATI: SHARE BUY-BACK PROGRAM TO SERVICE THE STOCK OPTION PLANS
|
English | 785.7 KB | ||
| 2021-02-22 18:22 |
RECORDATI: PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE A SERVIZIO DEI PIANI DI STOC…
|
Italian | 787.2 KB | ||
| 2021-02-22 15:32 |
Presentazione “2020 Preliminary FY results - 2021 Targets”
|
English | 871.6 KB | ||
| 2021-02-22 12:58 |
RECORDATI: PRELIMINARY 2020 RESULTS CONFIRM CONTINUED GROWTH OF OPERATING INCOM…
|
English | 353.9 KB | ||
| 2021-02-22 12:55 |
RECORDATI: RISULTATI PRELIMINARI 2020 CONFERMANO LA CONTINUA CRESCITA DEGLI UTI…
|
Italian | 333.6 KB | ||
| 2021-01-29 18:06 |
RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION OF ELIGARD IN EUROPE AND …
|
English | 273.7 KB | ||
| 2021-01-29 18:02 |
RECORDATI: OTTENUTA LICENZA PER LA COMMERCIALIZZAZIONE DI ELIGARD® IN EUROPA E …
|
Italian | 277.7 KB | ||
| 2021-01-05 18:52 |
Allegato 3F
|
Italian | 26.9 KB | ||
| 2021-01-05 18:22 |
ERRATA CORRIGE: Allegato 3F periodo di riferimento Novembre 2020
|
Italian | 27.9 KB | ||
| 2020-12-29 11:10 |
PUBLIC DISCLOSURE
|
English | 725.6 KB | ||
| 2020-12-29 11:07 |
ADEMPIMENTI INFORMATIVI VERSO IL PUBBLICO
|
Italian | 729.9 KB | ||
| 2020-12-29 10:48 |
Verbale dell'Assemblea Straordinaria degli azionisti del 17 dicembre 2020
|
Italian | 8.6 MB | ||
| 2020-12-18 12:41 |
RECORDATI: PUBLIC DISCLOSURE
|
English | 721.7 KB |
Automate Your Workflow. Get a real-time feed of all Recordati Industria Chimica e Farmaceutica filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Recordati Industria Chimica e Farmaceutica
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Recordati Industria Chimica e Farmaceutica via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
